Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
JAGX
JAGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JAGX News
Jaguar Health Reports Q1 Earnings Results
May 21 2026
seekingalpha
Jaguar Health Reports 816% Revenue Surge in Q1 2026
May 21 2026
NASDAQ.COM
Jaguar (JAGX) Q4 2025 Earnings Transcript
May 20 2026
NASDAQ.COM
Jaguar Health Announces Investor Webcast and Conference Presentation Dates
May 20 2026
Newsfilter
Jaguar Health Advances Crofelemer Development for Pediatric MVID
May 06 2026
Newsfilter
Geely's Strategic Positioning in the U.S. Market
May 04 2026
CNBC
Jaguar Health Launches Neonorm Dog Product Line
May 04 2026
NASDAQ.COM
Jaguar Health Advances Towards Full FDA Approval of Crofelemer
Apr 29 2026
Newsfilter
Jaguar Health Leverages AI for Crofelemer Treatment Advancement
Apr 14 2026
NASDAQ.COM
Jaguar Health Reports Q4 2025 Earnings Highlights
Apr 11 2026
Yahoo Finance
Jaguar Health Completes Study on Chemotherapy-Induced Diarrhea in Dogs
Apr 08 2026
Newsfilter
Jaguar Health Reports Q4 2025 Financial Results
Apr 08 2026
seekingalpha
Jaguar Announces Extension of MVID Clinical Trial
Mar 18 2026
Newsfilter
Life Sciences Virtual Investor Forum Highlights Available On-Demand
Mar 13 2026
Globenewswire
Life Sciences Virtual Investor Forum Agenda Announced
Mar 10 2026
Globenewswire
Jaguar Announces Special Stock Dividend to Protect Shareholders
Mar 02 2026
Yahoo Finance
Show More News
